Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: Meta-analysis of randomized placebo-controlled trials-Reference-Cited by-同舟云学术

Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: Meta-analysis of randomized placebo-controlled trials

Published:2007-07 Issue:7 Volume:22 Page:977-983
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Rudin Dan,Kiss Alexander,Wetz Robert V,Sottile Vincent M

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2007.04928.x/fullpdf

Reference38 articles.

1. Prevention of post-ERCP pancreatitis: a comprehensive review

2. Post-ERCP pancreatitis: is allopurinol the Holy Grail?

3. Pharmacological Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

4. Nifedipine for prevention of post-ERCP pancreatitis: A prospective, double-blind randomized study

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERCP後膵炎ガイドライン2023;Suizo;2024-04-30

2. Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis based on prospective, randomized, and controlled trials;Medicine;2023-10-13

3. An Insight on Pharmacological and Mechanical Preventive Measures of Post-ERCP PANCREATITIS (PEP)—A Review;Gastroenterology Insights;2022-12-02

4. Nafamostat Mesylate is Not Effective in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis;Digestive Diseases and Sciences;2021-01-25

5. Efficacy of octreotide (Octrade) for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography;Medical alphabet;2020-12-22